abstract: Cystic fibrosis (CF) is usually considered a rare disease in the Indian population. Two studies have reported on the frequency of cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in Indian males with congenital absence of the vas deferens (CAVD), however, data on the spectrum of CFTR gene mutations are still lacking. Therefore, the present study was designed to identify the spectrum of CFTR gene mutations as well as to investigate an association of CF genetic modifiers in the penetrance of CAVD in infertile Indian men. A total of 60 consecutive infertile males with a diagnosis of CAVD were subjected to CFTR gene analysis which revealed 13 different CFTR gene mutations and 1 intronic variant that led to aberrant splicing. p.Phe508del (n ¼ 16) and p.Arg117His (n ¼ 4) were among the most common severe forms of CFTR mutations identified. The IVS8-T5 allele, which is considered as a mild form of CFTR mutation, was found with an allelic frequency of 28.3%. Eight novel mutations were also identified in the CFTR gene from our patient cohort. It is noteworthy that the spectrum of CFTR gene mutation is heterogeneous, with exon 4 and exon 11 as hot spot regions. Moreover, we also found an association of the CF genetic modifiers, viz., transforming growth factor (TGF)-b1 and endothelial receptor type-A (EDNRA) genes with the CAVD phenotype. The findings are of considerable clinical significance because men suffering from infertility due to CAVD can decide to use artificial reproduction technology. The children of men with CAVD are at risk of carrying CFTR mutations; therefore, genetic counseling is a crucial step for such patients. With special reference to developing countries, such as India, where whole gene sequencing is not feasible, the outcome of our study will make the screening procedure for CFTR gene simpler and more cost-effective as we have identified hot spot regions of the CFTR gene which are more prone to mutation in Indian males with CAVD. Moreover, this is the first study from the Indian population to investigate the association of CF genetic modifiers with penetrance of the CAVD phenotype. The observed association of the genetic modifiers TGF-b1 and EDNRA in the penetrance of CAVD further supports their involvement in genesis of the vas deferens.
Introduction
Cystic fibrosis (CF, MIM#219700) is the most common severe autosomal recessive disorder among populations of European descendent (Welsh et al., 1995) . The incidence of CF varies from region to region (Estivill et al., 1997) and is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR gene is located on the long arm of chromosome 7 (region q31-q32), encompassing 250 kb and comprising 27 exons Riordan et al., 1989; Rommens et al., 1989) . More than 1900 sequence variants have been identified in the CFTR gene (http://www.genet.sickkids.on.ca/ StatisticsPage.html) and many of them have been implicated in a variety of CFTR-related pathologic conditions such as respiratory distress, pancreatic insufficiency, meconium ileus and congenital absence of the vas deferens (CAVD; Rosenstein and Cutting, 1998; Welsh et al., 2001; Kerem, 2006; Castellani et al., 2008) .
CAVD is characterized as an isolated urogenital form of CF which is associated with normal spermatogenesis, but absence of sperm in the ejaculate due to lack of a vas deferens (Anguiano et al., 1992) . More than 95% of males with CF are infertile due to obstructive azoospermia caused by absent, atrophic or fibrotic Wolffian duct structures (Chillon et al., 1995) . Genetic links between CF and CAVD were established due to the high frequency of the p.Phe508del mutation reported in patients with the CAVD phenotype (Anguiano et al., 1992) . The p.Phe508del, p.Arg117His and T5 allele were identified as most common CFTR mutations in Caucasians associated with CAVD phenotype (Chillon et al., 1995; De Braekeller and Ferec, 1996) . In intron 8 of the CFTR gene, presence of the IVS8-T5 allele leads to the omission of exon 9 in mRNA processing, thus CFTR with defective cAMP-activated chloride conductance results, in contrast with the other two alleles, T7 and T9, which predominantly generate normal mRNA transcripts. Henceforth, T5 is considered as a mild mutation (Chu et al., 1993; Teng et al., 1997) . Association of (TG)12 or (TG)13 repeats in intron 8 of CFTR gene with T5 allele enhance the severity of this mild mutation and it generally results in CAVD (Castellani et al., 2008) . Our recent study has provided evidence of extensive allelic heterogeneity in Indian patients with the genital form of CF (Sharma et al., 2009; Prasad et al., 2010) . Few investigations have shown that 80 -90% of patients with CAVD carry mutation in at least one CF allele, and the patients having both defective CFTR alleles are associated with severe mutations in one allele and a mild mutation in the second allele but never two severe mutations (Casals et al., 2000; Bareil et al., 2007) . Although a large percentage of patients with CAVD phenotype carry one defective allele of CFTR (Casals et al., 2000) , it is important to note that 3% of normal white males in the USA are the carrier of one defective CFTR allele but never develop CAVD (Baskin et al., 2002) . These finding suggest that a single defective CFTR allele may not be the only cause of the genital form of CF, and possibly other genetic or environmental factors must be involved in modifying penetrance of the CAVD phenotype.
Despite advances in understanding the pathophysiology of CF, there are still many inexplicable differences in its clinical association with CAVD. The role of CF genetic modifiers in intensifying the severity of classical CF is well established (Awad et al., 1998; Arkwright et al., 2000; Drumm et al., 2005; Darrah et al., 2010) . Transforming growth factor (TGF)-b1 codon 10 polymorphism (rs1800470) and codon 25 polymorphism (rs1800471) are reported to influence TGFb-1 protein level, which in turn may lead to pulmonary dysfunction in patients with classical CF (Yamada et al., 1998; Suthanthiran et al., 2000 , Dunning et al., 2003 Drumm et al., 2005) . Additionally, a role of the endothelial receptor type-A (EDNRA) gene polymorphism has been previously established in enhancing the severity of classical CF. Darrah et al. (2010) reported association of EDNRA gene polymorphism at positions -231 downstream from start codon AUG (rs1801708) and in exon 8 (rs5335) with a severe form of CF. It is noteworthy that TGF-b and endothelin are also involved in various other pathophysiological conditions, such as wound healing (Lawrence, 1996; Goraca, 2002) , extracellular matrix formation (Lawrence, 1996; Goraca, 2002) and lung fibrosis (Awad et al., 1998) , and importantly TGF-b has also been implicated in normal kidney development (Sanford et al., 1997) . Recently, the association of CF modifier EDNRA gene polymorphism rs5335 with penetrance of CAVD in the Turkish population has been reported (Havasi et al., 2010) .
In view of these facts, the present study was conducted to identify and characterize CFTR gene mutations in 60 infertile Indian males with CAVD. We also investigated whether TGF-b1 and EDNRA gene polymorphisms, reported to modify CF lung disease, also have role in influencing penetrance of the genital form of CF by acting as genetic modifiers of CAVD.
Methods

Ethical approval
The study was approved by the Institutional Ethics Committee at the Post Graduate Institute of Medical Education and Research, Chandigarh (Approval No.877/PG11-1TRG/16814 ). An information sheet was provided to each patient/family member and written informed consent was obtained.
Selection of subjects
A total of 60 consecutive Indian infertile men diagnosed as CAVD were included in this study. Healthy subjects (n ¼ 50) with sperm count .20 million/ml and without any symptoms of CF disease, such as respiratory failure or pancreatic insufficiency, served as controls. In all cases, the initial evaluation included a scrotal examination and a semen analysis. Overall, congenital bilateral absence of the vas deferens (CBAVD) was detected in 54 men, while six men had congenital unilateral absence of the vas deferens (CUAVD) with the absence of either the right (n ¼ 2) or left (n ¼ 4) vas deferens. Complete clinical data concerning infertility were evaluated in all patients diagnosed with CAVD. The diagnosis of CAVD was based on physical examination, when one or both vas deferentia were non-palpable in the scrotal portion. Semen analysis, including volume, pH, sperm count and motility, was performed in patients and controls, as per World Health Organization guidelines (World Health Organization, 2010) . Hormonal assays were done by chemiluminescence. Transrectal ultrasonography was conducted for the morphology and size of the seminal vesicles, prostate and ejaculatory ducts. Abdominal ultrasonography was performed in order to evaluate the pelvis and the upper urinary tract. Testicular fine needle aspiration cytology was carried out for studying the patterns of spermatogenesis. Sweat chloride analysis was performed in all the subjects (Gibson and Cooke, 1959) . None of the subjects had a family history of CF and the symptoms of classical CF were not detected in any of the subjects. All 60 patients had consulted for the couple's infertility. With the written consent of both partners, female partners (n ¼ 18) were also analyzed for the most common p.Phe508del mutation.
CFTR gene analysis
Genomic DNA was isolated from whole blood following the method of Daly et al. (1996) . For CFTR mutation analysis, chromosomes were first screened for the presence of p.Phe508del by Amplification Refractory Mutation System (ARMS) PCR, as described by Ferrie et al. (1992) . CFTR mutations, viz., p.Arg117His, p.Asn1303Lys and p.Arg553X were analyzed by single ARMS PCR, whereas mutations 621+1G.T, p.Gly542X, p.Gly551Asp and p.Trp1282X were screened by multiplex ARMS PCR. The T5 variant in the polymorphic region IVS8-T5 was analyzed as described previously (Chillon et al., 1995) .
The presence of novel/rare mutations in the 27 exons and at the exon intron boundaries of the CFTR gene were identified by single-strand conformational polymorphism (SSCP) analysis, as reported earlier (Sharma et al., 2009) . Amplified exons from healthy control DNA samples were also used in each run to prevent over interpretation of SSCP patterns as abnormal. The patient's samples exhibiting a shift relative to healthy control samples on SSCP were subjected to automated DNA sequencing with forward and reverse primers, using an ABI Prism Big Dye Terminator Sequencing Ready Reaction Kit (Perkin Elmer, USA) and a DNA sequencer ABI Prism (Model 3100, Perkin Elmer).
Genetic analysis of TGF-b1 and EDNRA genes polymorphism
Genomic DNA was isolated from the men with CAVD and 50 healthy controls with normal sperm count (.20 million/ml). TGF-b1 (rs1800470 and rs1800471) and EDNRA (rs5335, rs1801708) polymorphisms were analyzed as described by Havasi et al. (2010) with minor modifications. Primers used for amplification are listed in Supplementary data, Table SI. All the samples after amplification were subjected to automated DNA sequencing with forward and reverse primers, using an ABI Prism Big Dye Terminator Sequencing Ready Reaction Kit (Perkin Elmer, USA) and a DNA sequencer ABI Prism (Model 3100, Perkin Elmer). Despite our best attempts, DNA samples from 10 of the 60 males with CAVD could not be analyzed for CF genetic modifiers owing to repeated sequencing errors.
Pathological prediction and computational analysis
The output prediction score of all novel mutations was tested using software PolyPhen-2 (available at http://genetics.bwh.harvard.edu/pph2/). PolyPhen-2 is an automatic tool for prediction of the possible impact of an amino acid substitution on the structure and function of a human protein. This prediction is based on a number of features within the sequence, and phylogenetic and structural information characterizing the substitution. PMut, another online tool (prediction of pathological mutation) from molecular modeling and bioinformatics (mmb) software (http://mmb2.pcb.ub.es/pmut/temp/ pmut1380564661173/), was also used to validate results obtained from PolyPhen-2.
Statistical analysis
The exact relationship between the single nucleotide polymorphism (SNP) genotypes investigated and TGF-b1 or EDNRA activity are not known; therefore, a statistical assessment for each SNP was carried out with the assumption that both the dominant and recessive genotype has a genetic relationship with CAVD phenotype. SNP genotypes identified in the CAVD males were compared with controls using x 2 analysis. All statistical analysis was performed using the Statistical Package for the Social Sciences (IBM; Chicago, IL, USA) statistical software package. A value of P , 0.05 was considered significant.
Results
Demographics and clinical variables
The median age of the male CAVD patients at the time of enrollment was 28 years, and most of the patients consulted a urologist only after the evaluation of their female partner by a gynecologist. Mean + SD semen volume (1.0 + 0.61 ml) was much less in comparison to normal range (2 -4 ml); however, mean sweat chloride was in the intermediate range (40 -60 mEq/l; Table I ). Among eight patients identified with novel variant, only one with p.Gly126Cys mutation was observed with a slight elevated sweat chloride level (64mEq/l); however, in the remaining seven patients, sweat chloride level was in the intermediate range.
The mean serum hormone levels of FSH, LH and testosterone were in the normal range in CAVD patients; however, two CAVD patients with impaired spermatogenesis had an elevated FSH level (Table I) .
Mutations identified in the CAVD males
In total, 120 CFTR alleles were screened for mutations and we have identified 13 different mutations and 1 intronic variant (IVS8-T5) in 65 out of 120 alleles. p.Phe508del (n ¼ 16) and p.Arg117His (n ¼ 4) are the most common severe form of CFTR mutations identified in the Indian CAVD males. Both of these mutations were identified in the heterozygous condition in all patients (Table II) . The IVS8-T5 allele is another most common mild form of CFTR mutation observed in Indian infertile CAVD males. The IVS8-T5 was detected in 34 out of 120 CF chromosomes (Table II) . In 13% of CAVD males, this mild mutation was present in both the alleles, whereas in 15% of cases IVS8-T5 was detected in a compound heterozygous form with other mutations present in the coding region of the CFTR (Table III) . Patients identified as having either a single mutation or no mutations were subjected to SSCP analysis. SSCP analysis and subsequent DNA sequencing further revealed eleven mutations, viz., p.Gly480Ser, p.Ser549Asn, p.Arg518Lys, p.Gly126Cys, p.Ala141Gly, p.His139Gln, p.Ser118Pro, p.Arg170Cys, p.Glu585Gln, p.Met281Arg, p.Arg933Thr and two intronic variants c.1679+24G.T, c.1766+48G.C. Among them, eight mutations were novel and have been reported only in the Indian CAVD male population (Table II) . Among 50 healthy controls screened for the common mutations, viz., p.Phe508del, p.Arg117His and T5 allele, only seven of them were detected as a carrier of T5 allele (Table III and Supplementary data,  Table SII ). None of the other CFTR mutations were detected in the control group (Table III) .
Pathological predictions of novel substitution mutations
The PolyPhen-2 output prediction scores (http://genetics.bwh.harvard. edu/pph2/) for p.Gly126Cys, p.Ser118Pro, p.Met281Arg, p.Arg933Thr were more than 0.5 (threshold for pathological mutation) and therefore categorized as deleterious mutations and may possibly affect CFTR structure and function (Table IV) Role of TGFb-1 and EDNRA gene CF genetic modifiers in penetrance of CAVD Out of 60 males with CAVD screened for CFTR mutations, 50 Indian CAVD patients and 50 healthy controls were investigated for two previously described TGF-b1 (rs1800470, rs1800471) and EDNRA gene polymorphism (rs5335, rs1801708) associated with a more severe lung phenotype among subjects with CF. Among the remaining 10 CAVD subjects in whom TGFb-1 and EDNRA genotype analysis could not be performed due to sequencing errors, two were p.Phe508del/T5, three were T5/T5, the mutation p.Phe508del and T5 allele in the heterozygous state were detected in a single patient and in three patients no mutation could be identified. In the 50 subjects with CAVD screened for CF genetic modifiers, a CC allele at SNP rs5335 was found to be significantly prevalent in comparison to the control group (44 versus 22%, P , Table  SIV ). TGF-b1 polymorphism rs5335 and EDNRA polymorphism rs1800470 in CAVD patients bearing a CFTR mutation in one or both alleles was compared with control subjects having a T5 allele (Table VIII) . A CC genotype at SNP rs5335 (EDNRA) was prevalent only in males with CAVD having a CFTR mutation (n ¼ 18) and was not observed in the seven healthy controls carrying the IVS8-T5 allele mutation. Moreover, a CC genotype at SNP rs5335 was found in 46.4% (13/28) of CAVD males bearing CFTR mutations in a single allele (Table VIII) . Similarly, TGF-b1 TT genotype at SNP rs1800470 is more common in CAVD males with a CFTR mutation (n ¼ 23) in comparison to control group. TGF-b1 TT genotype at SNP rs1800470 was observed only in one of seven healthy controls who are the carrier of IVS8-T5 allele (Table VIII) . On the other hand, TT allele was found in 57.14% (16/28) of CAVD males carrying a mutation in a single allele of the CFTR gene (Table VIII) .
Clinical phenotype and its association with genotype
In this study, we have investigated 60 patients with CAVD: 54 of them had CBAVD, whereas six have CUAVD. Genotype GC (rs5335) at EDNRA and TT genotype (rs1800470) at TFG-b1 was observed in five patients with unilateral absence of the vas deferens. Three patients presented with absence of a single kidney. No severe mutation was identified in any patient with a single kidney; however, one of them also had the unilateral absent seminal vesicle and was associated with the IVS8-T5 mutation in a single allele. Patients with CAVD bearing other forms of abnormality, such as absence of seminal vesicle (n ¼ 9), absence of epididymis (n ¼ 5) or obstruction in ejaculatory duct (n ¼ 3), bear mutations in CFTR in one or the other allele. Genotype GC at EDNRA (rs5335) was observed in 13 (72%) patients associated with one or other form of renal abnormality. However, a specific association between CFTR gene mutations and different forms of urogenital abnormalities could not be established. Three of the six patients with CUAVD also have unilateral absence of seminal vesicle predominantly on the same side as the absent vas deferens. One patient with a T5/ p.Ser549Asn genotype presented with the symptoms of repeated respiratory infection since childhood.
Discussion
The present study demonstrated a heterogeneous spectrum of CFTR gene mutations in Indian infertile CAVD males. p.Phe508del was identified as most common mutation, with a 13.3% allelic frequency in our CAVD population. Genetic analysis of the CFTR gene led to the identification of mutations in 81% of Indian CAVD males and this detection rate is very similar to that of Caucasians (Oates and Amons, 1994; Dork et al., 1997; Kanavakis et al., 1998; Casals et al., 2000; Claustres et al., 2000) . In accordance with a previous study, the spectrum of CFTR gene mutations in Indian CAVD males is completely different from that of Caucasians. However, the allelic frequency of p.Phe508del mutation (13.3%) in our population is similar to that of Greece (12 -14%; Kanavakis et al., 1998) and Portugal (Grangeia et al., 2004) , but lower than in Canada (21-33%; Jarvi et al., 1998), USA (Oates and Amos, 1994) , Germany (Dork et al., 1997) , France (Claustres et al., 2000) and Spain (Casals et al., 2000) . The second most common mutation identified was p.Arg117His observed with an allelic frequency of 3.3%, and this frequency is similar to that of France (Grangeia et al., 2004) and Greece (Estivill et al., 1997) but lower than that of Germany (11%; Dork et al., 1997) . Two of the patients with a p.Arg117His heterozygous mutation were associated with a T7 allele, which is considered a mild CFTR mutation in Europe and may lead to the CAVD phenotype (Thauvin et al., 2009) . The T5 allele is one of the most frequent genotypes found in combination with CFTR mutations in CAVD patients (Chillon et al., 1995) . The T5 allele in Indian CAVD patients was found with an allelic frequency of 28%, which is very similar to that of Canada (21-27%; Jarvi et al., 1998; Mak et al., 1999) , Brazil (Bernardino et al., 2003) , Spain (Casals et al., 2000) , Croatia (Sertic et al., 2001) and Italy (Gelfi et al., 1998) , however, it was higher than that found (10 -18%) in the USA (Wang et al., 2002) , the Netherlands (Dohle et al., 1999) , Germany (Dork et al., 1997) , France (Claustres et al., 2000) and Greece (Kanavakis et al., 1998) , and lower than that of Israel (44 -56%; Rave-Harel et al., 1997) and Egypt (Lissens et al., 1999) . A (TG)12 or (TG)13 repeat immediately upstream of T5 repeats in intron 8 predominantly increase penetrance of the T5 allele, resulting in a CBAVD phenotype. In our previous study, we have demonstrated a high allelic frequency of (TG)12T5 or (TG)13T5 CFTR gene in Indian CAVD males (Sharma et al., 2009) .
Intriguingly, extensive screening of 27 exons of CFTR in Indian CAVD males leads to the identification of eight novel substitutions which are reported only in the Indian population and three mutations, viz., p.Gly480Ser, p.Ser549Asn and p.Arg170Cys, which have been reported previously (Curtis et al., 1993; Fere et al., 1994; Kawose et al., 2001) . Out of eight novel substitutions, five were identified in exon 4 comprising the MSD1domainoftheCFTRprotein.Overall,exon11comprisingtheNBD1 region of CFTR as well as exon 4 are the identified hot spot regions for screening CFTR mutations in infertile Indian males with CAVD. The lack of a multi-center study limits the sample size, therefore it is difficult for us to establish a panel of CFTR mutations for Indian CAVD males. As the frequency of novel substitutions identified in the Indian CAVD male is very low, we can include only p.Phe508del, p.Arg117His and T5 in mutation screening panel. In the absence of any of these common mutations, complete screening of all 27 exons of the CFTR gene is recommended for infertile males with CAVD who decide to undergo artificial reproduction techniques. This work has substantial clinical and genetic counseling implications for Indian patients with CAVD, as the existence of CF in India is now well documented (Kabra et al., 2000; Shastri et al., 2008; Sharma et al., 2009) , but no study to date has highlighted region(s) of the CFTR gene which are most prone to mutation.
Among the eight novel mutations identified, p.Ser118Pro, p.Met281Arg, p.Gly126Cys, p.Arg933Thr were predicted to be damaging, whereas p.Arg518Lys, p.Ala141Gly, p.His139Gln, p.Glu585Gln were possibly neutral mutations (http://genetics.bwh.harvard.edu/ pph2/). This in silico analysis was performed to predict the damaging effect of identified novel CFTR variants as some of the variants may be functional at transcriptional level. Moreover, none of these novel mutations have been detected in any of the healthy controls screened, hence there is a probability that four of the novel mutations which are predicted to be damaging are affecting CFTR function and may lead to the CAVD phenotype. However, in vitro functional studies are required to determine the exact pathological effect(s) of the identified novel mutations. In the present study, a large proportion of CAVD patients were identified with either one or no mutation, which could be due to presence of mutations within the intron or promoter regions which were not analyzed. The presence of large rearrangement, such as exon deletions, insertions or duplication, has been described in 2-6% of Caucasian males with the CAVD phenotype (Hantash et al., 2006; Ratbi et al., 2007; Taulan et al., 2007) . Although the probable occurrence of large CFTR gene rearrangement in CAVD phenotype is not very common, nevertheless large deletions and duplication which were not analyzed might be another cause of failure to identify mutations in any of the CFTR alleles in 18% of CAVD males. Patients with the classical CF carry severe mutations in both alleles, whereas the patients with isolated CAVD are usually heterozygous for a mild mutation on one allele and a severe mutation on the second allele (Grangeia et al., 2007) . It is noteworthy here that the presence of severe mutations in one allele can reduces only CFTR activity to half of the normal level. Some investigators have reported that, in order to cause isolated CAVD, CFTR function should be ,8%, but it has to be more than 3, as 8% is the minimal level for a normal phenotype and 3% is the level below which severe CF occurs (Wong et al., 2004; Disset et al., 2005) . So we hypothesize that the presence of a mild mutation/variant or severe mutation on a single allele of CFTR along with modifier genes may block the development of the vas deferens. Therefore, further study is needed to ascertain any association of other modifier genes, such as TGF-b1 and EDNRA, in genesis of the vas deferens. It is well established that TGFb-1 and EDNRA are important modifiers of CF pulmonary phenotype but in this study we have investigated the possible involvement of these modifiers in the penetrance of CAVD phenotype. This is the first study related to the Indian population where we identify possible involvement of these pathways in an atypical CF-related condition, namely CAVD. We found that TGFb-1 rs1800470 and EDNRA rs5335 polymorphisms, known to exacerbate pulmonary inflammation in classical CF, also appear to be associated with CAVD phenotype. From the previous studies, it is known that TGFb and associated signaling pathways operate in Wolffian duct development and differentiation and the Wolffian duct is critically involved in formation of the vas deferens, epididymis and seminal vesicle (Sanford et al., 1997; Stenvers et al., 2003; Hannema et al., 2006) . Recently, it has also been shown that TGFb-1, via TGFb-1 receptor and P38 MAPK signaling, reduce CFTR activity and will probably enhance the effect associated with heterozygous CFTR mutations and may result in male infertility (Yi et al., 2013) . Vas deferens formation is a complex process and multiple signaling pathways are associated with CAVD phenotype, consequently a significant role for TGFb-1 and EDNRA gene during the development of vas deferens cannot be denied. An important role of EDNRA has been observed previously in the normal mammalian nervous system, the anorectum, and in formation of craniofacial structures, such as the mandible (Pla and Larue, 2003; Ruest et al., 2004; Stanchina et al., 2006; Moore and Zaahl, 2007) . The association of EDNRA gene polymorphism at rs5335 with urogenital anomalies in CAVD cases, such as absence of kidney, epididymis or seminal vesicle, support the hypothesis of involvement of gene modifiers in distinct CF phenotypes, such as CAVD. However, further study of large patients cohort from Indian populations as well as analysis of functional pathways of these modifiers is required to support a role of these modifiers in penetrance of CAVD.
Supplementary data
Supplementary data are available at http://molehr.oxfordjournals.org/.
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